More Investing
View Older Stories View Newer Stories-
Fed's Miran says rate cuts still appropriate despite Middle East war
-
Wolfe warns S&P 500 may drop to as low as 6500 before staging another rally
-
BofA lists three top automaker picks for 2026
-
Billionaire Leo KoGuan buys 1 million Nvidia shares, says AI "not a bubble"
-
Pentagon reports US achieves air superiority over Iran four days into operation
-
Moderna shares jump as settlement removes major legal overhang
-
Geopolitical shock prompts risk reduction - Citi
-
GitLab downgraded at Piper Sandler as guidance clouds outlook; stock dips
-
Abercrombie & Fitch beats estimates, shares rise
-
NATO defenses shield Turkey as Iran conflict spills into alliance territory
-
Dycom shares climb after Q4 earnings and revenue top estimates
-
Bessent says 15% tariff rate likely to take effect this week
-
Libya 2011 offers playbook for S&P 500 in Iran conflict: Citi
-
Bank of America resumes Tesla stock coverage. Here's the new price target
-
Bath & Body Works shares rise as Q4 beats estimates
-
ECB blog suggests AI may create jobs rather than eliminate them
-
Fed's Hammack backs extended rate pause, cites Iran war uncertainty
-
Lockheed Martin Wins $1.9B Contract for C-130J Training Systems
-
FDA issues 30 warning letters to telehealth firms over GLP-1 claims
-
Iran’s rope-a-dope: The war of attrition in the Persian Gulf
-
BofA upgrades Unity as stock price has baked in much of downside risks
-
Trump says US will provide insurance, military escort for ships in Hormuz
-
US reportedly mulls military protection for Hormuz oil tankers
-
ASM rises after posting Q4 beat, strong 2026 outlook
-
Spain trade embargo? Trump orders Treasury Secretary Bessent to halt dealings
-
iShares MSCI Spain ETF tumbles on Trump trade threat
-
CoStar Group stock rises after CEO buys $2.5M in shares
-
Fed’s Williams: too early to assess Iran war impact on US economy
-
Small businesses face cost pressures from tariffs and inflation, Fed survey shows
-
uniQure downgraded after FDA backs sham-controlled trial for Huntington’s therapy
-
Apollo CEO warns of shakeout in private credit amid rising defaults
-
Trump tells Politico Iran is running out of weapons
-
Exclusive: DriveWealth CEO on bringing prediction markets to global portfolios
-
Fed’s Schmid says inflation still nearly a point above target
-
EU firms handle US tariffs well but face internal trade barriers, survey shows
-
Blackstone sinks after $1.7 bln net outflows from flagship private credit fund
-
Fed's Williams says rate cuts possible if inflation slows
-
Buy the dip in this AI chipkamer, HSBC says
-
Nvidia's $78 billion sales outlook defies scale concerns
-
The Upbound pivot: An exclusive conversation with CEO Fahmi Karam
-
HSBC upgrades Block, cites 'material increase in earnings power
-
InfuSystem stock gains after CFO buys shares
-
eHealth stock surges 17% on CEO insider buying
-
Russell 2000: how exposed is it to the Iran shock?
-
Trump says U.S. has enough weapons to fight wars ’forever’
-
Sportradar shares tumble despite record results and buyback boost
-
Software shorts at the highest since the GFC, Deutsche Bank says
-
AeroVironment bounces jumps 6.5% on Space Force contract talks
-
Best Buy surges on earnings beat
-
AutoZone shares fall as FQ2 revenue misses forecasts
